8 completed, 3 withdrawn, 2 terminated, 2 unknown. 17 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 17 | Completed 8, Withdrawn 3, Terminated 2, Unknown 2, Active not recruiting 1, Recruiting 1 |
Follow Elimination Disorders: new trials by email Literature Review of Elimination Disorders trials Research Report on Elimination Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comprehensive Toileting Program Glycerin Suppository, Behavioral strategies - Encopresis, ASD | Phase 4 | Recruiting | Emory University | 150 | 2026-06-01 | 2026-06-18 |
| Use of the LEVA® Pelvic Health System for Fecal Incontinence The Leva Pelvic Health System - Fecal Incontinence | Phase 4 | Active not recruiting | University of Wisconsin, Madison | 38 | 2024-01-17 | 2026-09-28 |
| Topical Vaginal Estrogen for Postpartum Obstetric Anal Sphincter Injury Recovery Estradiol 0.01% Vag Cream, Placebo vaginal cream - Obstetric; Injury Pelvic Floor, Sexual Dysfunction | Phase 4 | Terminated | University of Alabama at Birmingham | 38 | 2022-07-14 | 2026-02-18 |
| Desmopressin for Bedwetting in Children With SCD Desmopressin - Nocturnal Enuresis, Anemia, Sickle Cell | Phase 4 | Terminated | Montefiore Medical Center | 8 | 2020-07-07 | 2024-05-07 |
| Urotherapy vs. Urotherapy With Constipation Treatment for Nocturnal Enuresis Polyethylene glycol 3350, Constipation behavioral therapy, Urotherapy - Nocturnal Enuresis | Phase 4 | Withdrawn | Rabin Medical Center | 2020-06-01 | 2018-04-11 | |
| Posterior Tibial Nerve Stimulation Vs Desmopressin In Children With Primary Monosymptomatic Nocturnal Enuresis Posterior tibial nerve stimulation, Desmopressin Acetate - Primary Monosymptomatic Nocturnal Enuresis | Phase 4 | Unknown | Cairo University | 80 | 2020-03-15 | 2020-09-11 |
| Urotherapy vs. Urotherapy With Constipation Treatment for Children With Lower Urinary Tract Dysfunction polyethylene glycol 3350, Constipation behavioral therapy, Urotherapy - Diurnal Enuresis | Phase 4 | Withdrawn | Rabin Medical Center | 2020-01-01 | 2018-04-11 | |
| The Effect of Selecting Treatment With Desmopressin or Alarm to Children With Enuresis Based on Home Recordings. Desmopressin, Conditional alarm - Enuresis, Nocturnal | Phase 4 | Completed | University of Aarhus | 324 | 2017-10-01 | 2023-08-02 |
| Mebeverine For 1st Year Daytime And Nocturnal Incontinence After Orthotopic W-Ileal Neobladders Coloverin, Placebo - Oncology, Incontinence | Phase 4 | Completed | Mansoura University | 110 | 2017-05-15 | 2020-06-30 |
| A New Check-list Method for Nocturnal Enuresis desmopressin melt form 120 μg, Verbal behavioral therapy, Behavioral therapy with written check-list - Nocturnal Enuresis | Phase 4 | Completed | Ankara Training and Research Hospital | 75 | 2015-01-01 | 2018-05-01 |
| Intranasal Steroids for the Treatment of Nocturnal Enuresis With Associated Obstructive Sleep Apnea Bed Alarm, Nasonex - Enuresis, Obstructive Sleep Apnea | Phase 4 | Withdrawn | University of Alberta | 2013-05-01 | 2015-12-18 | |
| Polyacrylamide Hydrogel Injection Treatment for Anal Incontinence Transanal submucosal injection group 1, Transanal submucosal injection group 2, Transanal submucosal injection group 3 - Anal Incontinence | Phase 4 | Completed | Karolinska Institutet | 30 | 2013-01-01 | 2016-01-12 |
| Desmopressin for Improving Nocturnal Enuresis in Patients After Radical Cystectomy With Bladder Reconstruction Desmopressin - Nocturnal Enuresis | Phase 4 | Unknown | Rabin Medical Center | 50 | 2012-04-01 | 2012-04-20 |
| Desmopressin Melt: Impact on Sleep and Daytime Functioning Desmopressin lyophilisate (Melt) - Monosymptomatic Nocturnal Enuresis | Phase 4 | Completed | University Hospital, Ghent | 30 | 2011-04-01 | 2022-12-15 |
| Influence of Food-intake on Desmopressin Oral Tablets and MELT-formulation desmopressin tablet, desmopressin MELT formulation - Enuresis, Polyuria | Phase 4 | Completed | University Hospital, Ghent | 24 | 2009-12-01 | 2019-02-06 |
| The Effect of Indomethacin in Monosymptomatic Enuresis Nocturnal Indomethacin - Enuresis | Phase 4 | Completed | University of Aarhus | 56 | 2003-01-01 | 2010-06-25 |
| A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal Enuresis Primary nocturnal enuresis - Nocturnal Enuresis | Phase 4 | Completed | Ferring Pharmaceuticals | 802 | 2002-04-01 | 2011-05-19 |
Nocturnal Enuresis (8) · Encopresis (4) · Enuresis (4) · Constipation (2) · Diurnal Enuresis (2) · Anemia, Sickle Cell (1) · Fecal Incontinence (1) · Neoplasms (1) · Patient Compliance (1) · Polyuria (1) · Sexual Dysfunction, Physiological (1) · Sleep Apnea Syndromes (1) · Sleep Apnea, Obstructive (1) · Urinary Bladder Neoplasms (1) · Urinary Incontinence (1)
Behavior (17) · Behavioral Symptoms (17) · Mental Disorders (17) · Female Urogenital Diseases (14) · Female Urogenital Diseases and Pregnancy Complications (14) · Male Urogenital Diseases (14) · Urination Disorders (14) · Urogenital Diseases (14) · Urologic Diseases (14) · Enuresis (9) · Pathological Conditions, Signs and Symptoms (7) · Signs and Symptoms (7) · Signs and Symptoms, Digestive (6) · Urological Manifestations (2)
Deamino Arginine Vasopressin (5) · Freezing (2) · polyethylene glycol 3350 (2) · Behavior Therapy (1) · Estradiol (1) · Indomethacin (1) · Mometasone Furoate (1) · Vaginal Creams, Foams, and Jellies (1) · mebeverine (1)
Rabin Medical Center (3) · University Hospital, Ghent (2) · University of Aarhus (2) · Ankara Training and Research Hospital (1) · Cairo University (1) · Emory University (1) · Ferring Pharmaceuticals (1) · Karolinska Institutet (1) · Mansoura University (1) · Montefiore Medical Center (1) · University of Alabama at Birmingham (1) · University of Alberta (1) · University of Wisconsin, Madison (1)
United States (4) · Belgium (3) · Israel (3) · Denmark (2) · Egypt (2) · Canada (1) · China (1) · France (1) · Poland (1) · Turkey (Türkiye) (1)
Johan Vande Walle, MD, PhD (2) · Ahmed Elhussein, MBBCH (1) · Ahmed Elkarta, MBBCH (1) · Ahmed Mosbah, MD (1) · Ahmet M Hascicek, M.D. (1) · Daniel Altman, MD, PhD (1) · Dobie Giles, MD (1) · Hannah L Chapman, MD (1) · Hany A Morsi, Professor (1) · Hassan Abol-Enein, MD (1) · Kerry Morrone, MD (1) · Konstantinos Kamperis, MD. PhD (1) · Mindy Scheithauer, PhD (1) · Mohamed Soltan, MBBCH (1)
PMID 40728007, PMID 19125991, PMID 23881652, PMID 25504157, PMID 26059526, PMID 27067081, PMID 27787700, PMID 28888814, PMID 38950376
R01HD115933 (1)